Screws tightened on drug pricing - The New Indian Express

Screws tightened on drug pricing

Published: 30th September 2013 10:34 AM

Last Updated: 30th September 2013 10:34 AM

As it moves towards a tighter regulatory environment, the National Pharmaceutical Pricing Authority (NPPA), said pharma companies in will get 15 days to respond once the price revision notification is made.

Those representations received after 15 days will be treated as ‘time barred’ and will be rejected as ‘non entertainable’ without actually going into mertids.

Prices of 348 drugs included in the national list of essential medicines are to be fixed under the new drug policy that came into force last year.

The authority also said, it has been receiving representations from manufacturers seeking clarifications and corrections particularly with regards to applicability of price notifications on their products as well as regarding errors of omissions and miscalculations.

“However, as this exercise cannot be open ended, the authority has decided to fix a time limit. It has been decided that representations received within 15 days from the date of notification may be accepted and these will be dealt within 15 days of the receipt of the representation,” said NPPA adding that the ceiling prices of 338 scheduled medicines have been notified so far.

So far, the authority has held seven meetings since June 2013 and approved fixing the ceiling prices based on data furnished by IMS Health, under DPCO 2013. NPPA has been collecting information from manufacturers wherever the data provided by IMS is incomplete.

From Around the Web